Optimizing Clinical Study Report Development Through Lean Authoring: A Framework for Meeting Regulatory Expectations...

Area of Science:

• Pharmaceutical industry
• Medical writing
• Regulatory affairs

Background:

• Efficient creation of clinical documents like clinical study reports (CSRs) is crucial in the pharmaceutical industry.
• Current document creation processes can be inefficient and lead to lengthy regulatory reviews.
• Medical writing leaders advocate for improved authoring methodologies.

Purpose of the Study:

• To provide a comprehensive overview of lean authoring in the pharmaceutical sector.
• To emphasize the importance of lean authoring for efficient CSR and clinical document creation.
• To outline a step-by-step approach for adopting lean authoring methods and managing change.

Main Methods:

• Review of experiences from medical writing leaders in the pharmaceutical industry.
• Definition and explanation of lean authoring principles and their application.
• Discussion of strategies to overcome implementation challenges, including resistance to change.

Main Results:

• Lean authoring delivers unambiguous, clear, concise, and objective content tailored to regulatory reviewer needs.
• Benefits include improved readability, content reusability, enhanced efficiency, cost-effectiveness, and more efficient regulatory reviews.
• Adoption of lean authoring can lead to fewer review questions and reduced burden on reviewers.

Conclusions:

• Lean authoring optimizes the document creation process in the pharmaceutical industry.
• It improves the quality of CSRs and increases the efficiency of regulatory reviews.
• Adopting lean authoring aligns with healthcare agency preferences for clear and concise information.